Ignite Creation Date:
2025-12-25 @ 4:57 AM
Ignite Modification Date:
2025-12-26 @ 3:56 AM
Study NCT ID:
NCT03208218
Status:
COMPLETED
Last Update Posted:
2017-07-06
First Post:
2017-06-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Crossover Study to Compare Pharmacokinetic Property of SYP-1512 Tab and Revlimid Cap in Healthy Male Volunteers
Sponsor:
Samyang Biopharmaceuticals Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-08-17
Start Date Type:
ACTUAL
Primary Completion Date:
2016-08-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-10-31
Completion Date Type:
ACTUAL
First Submit Date:
2017-06-25
First Submit QC Date:
None
Study First Post Date:
2017-07-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-04
Last Update Post Date:
2017-07-06
Last Update Post Date Type:
ACTUAL